je.st
news
Tag: discovery
PeptiDream Announces Peptide Discovery Collaboration Agreement With Genentech
2016-01-06 06:26:00| drugdiscoveryonline Home Page
PeptiDream Inc., a public Tokyo-based biopharmaceutical company (“PeptiDream”) recently announced a multi-target discovery and optimization collaboration with US-based Genentech Inc., (“Genentech”), a member of the Roche Group
Tags: agreement
collaboration
discovery
announces
Emulate Announces Expanded Collaboration With Merck To Use Organ-Chips In Drug Discovery And Development Process For Inflammatory Diseases
2016-01-06 06:17:13| drugdiscoveryonline Home Page
Emulate Inc. recently announced an expanded research collaboration with Merck, known as MSD outside the United States and Canada, to deploy Emulate’s Organ-Chips across certain Merck discovery programs to improve models of human inflammatory diseases and better predict the potential human response of therapeutic candidates
Tags: development
process
drug
expanded
Tetragenetics Launches Partnership Program For Discovery And Development Of Therapeutic Monoclonal Antibodies
2016-01-06 06:05:47| drugdiscoveryonline Home Page
Tetragenetics Inc., an emerging biotechnology company engaged in the expression of ion channel drug targets, announced recently a new partnership program for the discovery and development of therapeutic monoclonal antibodies (mAbs) directed against well-known ion channel drug targets implicated in a wide range of disease states –such as pain and autoimmune disorders
Tags: development
program
partnership
discovery
Oncodesign Biotechnology And Bristol-Myers Squibb Enter Into Strategic Drug Discovery Collaboration
2016-01-06 06:00:34| drugdiscoveryonline Home Page
ONCODESIGN (Alternext – ALONC), a biotechnology company serving the pharmaceutical industry in the discovery of new therapeutic molecules to fight cancer and other serious illnesses with no known effective treatment, recently announced that it has entered into a strategic collaboration agreement with Bristol-Myers Squibb Company to discover, develop and commercialize novel macrocyclic compounds
Tags: enter
drug
collaboration
strategic
Zacks Investment Research Lowers Discovery Laboratories, Inc. (DSCO) to Sell
2015-12-29 06:13:10| Biotech - Topix.net
According to Zacks, "Discovery Laboratories, Inc., formerly known as Ansan Pharmaceuticals, Inc., is a development-stage pharmaceutical company that focuses on developing compounds to treat respiratory diseases that affect the ability of the lungs to absorb oxygen. It is initially developing its lead product candidate, Surfaxin, for use by newborn infants to treat two respiratory conditions in critical care units of hospitals.
Tags: research
sell
investment
discovery
Sites : [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] next »